isoproterenol has been researched along with gsk-j4 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, K; Guo, Z; Li, J; Li, Z; Liu, P; Lu, J; Wang, J; Wang, P; Ye, J; Zhong, Y | 1 |
1 other study(ies) available for isoproterenol and gsk-j4
Article | Year |
---|---|
JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing β-MHC expression.
Topics: Animals; Animals, Newborn; Benzazepines; Cardiomegaly; Demethylation; Gene Knockdown Techniques; Histones; Isoproterenol; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Methylation; Mice, Inbred C57BL; Myocytes, Cardiac; Myosin Heavy Chains; Promoter Regions, Genetic; Pyrimidines; Rats, Sprague-Dawley; Up-Regulation | 2018 |